Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to “wear and tear” on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.
The report details the trend, potential and market size of Arthritis Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Arthritis Drugmarket, defines the market attractiveness level of Arthritis Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Arthritis Drug industry, describes the types of Arthritis Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Arthritis Drug market and the development prospects and opportunities of Arthritis Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Arthritis Drug market in Chapter 13.
By Player:
Eli Lilly
Celltrion
Novartis
Johnson & Johnson
F Hoffmann-La Roche
GSK
Pfizer
By Type:
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics
By End-User:
Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Arthritis Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Arthritis Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Arthritis Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Arthritis Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Arthritis Drug Market Analysis and Outlook to 2022
-
7.1 Global Arthritis Drug Consumption (2017-2022)
-
7.2 United States Arthritis Drug Consumption (2017-2022)
-
7.3 Europe Arthritis Drug Consumption (2017-2022)
-
7.4 China Arthritis Drug Consumption (2017-2022)
-
7.5 Japan Arthritis Drug Consumption (2017-2022)
-
7.6 India Arthritis Drug Consumption (2017-2022)
-
7.7 South Korea Arthritis Drug Consumption (2017-2022)
8 Region and Country-wise Arthritis Drug Market Analysis and Outlook to 2028
-
8.1 Global Arthritis Drug Consumption Forecast (2022-2028)
-
8.2 United States Arthritis Drug Consumption Forecast (2022-2028)
-
8.3 Europe Arthritis Drug Consumption Forecast (2022-2028)
-
8.4 China Arthritis Drug Consumption Forecast (2022-2028)
-
8.5 Japan Arthritis Drug Consumption Forecast (2022-2028)
-
8.6 India Arthritis Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Arthritis Drug Consumption Forecast (2022-2028)
9 Global Arthritis Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Arthritis Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Synthetic DMARDs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Biological DMARDs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global NSAIDs Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Analgesics Consumption and Growth Rate (2017-2022)
-
9.2 Global Arthritis Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drug Stores Consumption and Growth Rate (2017-2022)
-
9.2.4 Global E-Commerce Consumption and Growth Rate (2017-2022)
10 Global Arthritis Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Arthritis Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Synthetic DMARDs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Biological DMARDs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global NSAIDs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Arthritis Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global E-Commerce Consumption Forecast and Growth Rate (2022-2028)
11 Global Arthritis Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Arthritis Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Arthritis Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Arthritis Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Arthritis Drug Market Competitive Analysis
-
14.1 Eli Lilly
-
14.1.1 Eli Lilly Company Details
-
14.1.2 Eli Lilly Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly Arthritis Drug Product and Service
-
14.2 Celltrion
-
14.2.1 Celltrion Company Details
-
14.2.2 Celltrion Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Celltrion Arthritis Drug Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Arthritis Drug Product and Service
-
14.4 Johnson & Johnson
-
14.4.1 Johnson & Johnson Company Details
-
14.4.2 Johnson & Johnson Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Johnson & Johnson Arthritis Drug Product and Service
-
14.5 F Hoffmann-La Roche
-
14.5.1 F Hoffmann-La Roche Company Details
-
14.5.2 F Hoffmann-La Roche Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 F Hoffmann-La Roche Arthritis Drug Product and Service
-
14.6 GSK
-
14.6.1 GSK Company Details
-
14.6.2 GSK Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GSK Arthritis Drug Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Arthritis Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Arthritis Drug
-
Figure Arthritis Drug Picture
-
Table Global Arthritis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Arthritis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Arthritis Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Arthritis Drug Consumption by Country (2017-2022)
-
Figure United States Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure China Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure India Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Arthritis Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Synthetic DMARDs Consumption and Growth Rate (2017-2022)
-
Figure Global Biological DMARDs Consumption and Growth Rate (2017-2022)
-
Figure Global NSAIDs Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Analgesics Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global E-Commerce Consumption and Growth Rate (2017-2022)
-
Figure Global Synthetic DMARDs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biological DMARDs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NSAIDs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global E-Commerce Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Arthritis Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Arthritis Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Arthritis Drug Product and Service
-
Table Celltrion (Foundation Year, Company Profile and etc.)
-
Table Celltrion Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celltrion Arthritis Drug Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Arthritis Drug Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Arthritis Drug Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Arthritis Drug Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Arthritis Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Arthritis Drug Product and Service
-
